Johan Vansteenkiste

Papers

Total Citations

H-Index

About

Johan Vansteenkiste is a leading figure in thoracic oncology, whose work has profoundly shaped the management of lung cancer over the past four decades. His research primarily focuses on early-stage non-small cell lung cancer (NSCLC), with major contributions to the evolution of multimodal treatment strategies, including the integration of chemotherapy and targeted therapies. His seminal review, "Early Stage Lung Cancer: Progress in the Last 40 Years" (2014), with 22 citations, provides a comprehensive synthesis of key advances—from surgical techniques to adjuvant therapies—highlighting the dramatic improvements in survival and quality of life for patients. Vansteenkiste’s impact extends beyond this review; he has been instrumental in pivotal clinical trials that established new standards of care, particularly in the perioperative setting. His work has not only guided clinical practice but also inspired a generation of researchers to pursue innovative approaches in early detection and personalized treatment. With a career marked by rigorous scholarship and translational impact, Vansteenkiste remains a vital voice in the fight against lung cancer.